Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-02-07
1985-09-03
Rosen, Sam
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514832, A61K 3712
Patent
active
045392048
ABSTRACT:
A composition of matter which comprises a synthetic whole blood useful as a replacement for whole mammalian blood and a method of making the same are disclosed. The method of manufacture makes use of two gelatins, two modified fluid gelatins, or one gelatin and one modified fluid gelatin of differing isoelectric points, and selected additives. The invention also contemplates the use of only one gelatin or only one modified fluid gelatin, plus lecithin. The invention also contemplates using stroma free hemoglobin, microencapsulated stroma free hemoglobin, or synthetic liposomes containing stroma free hemoglobin incorporated in either the coacervate phase or the coacervate system of this invention. The method yields a two phase liquid aqueous system which successfully duplicates the two phase heterogeneous physico-chemical system of naturally occurring whole blood. The disclosed composition possesses many of the physiological capabilities of whole human blood.
REFERENCES:
patent: 4001401 (1977-01-01), Bonsen
patent: 4002739 (1977-01-01), Turner et al.
Arthur Osol, ed., Remington's Pharmaceutical Sciences (Easton, Pennsylvania: Mack Publishing Co., 1975), p. 315.
Bucala et al.--Science, vol. 220, May 1983, pp. 965-967.
P. Lundsgaard-Hansen, M.D. and B. Tschirren, M.D., "Modified Fluid Gelatin as a Plasma Substitute", Blood Substitutes and Plasma Expanders, (New York: Alan R. Liss, 1978), p. 227.
Information in a letter to B. H. Gold, M.D. from H. U. Frey, M.D., Director of the Blood Transfusion Service, Central Laboratory, Berne, Switzerland, Dec. 6, 1982 and Jan. 5, 1983.
"Blood", Van Nostrand's Scientific Encyclopedia, 1968, pp. 214-215.
Gessner G. Hawley, ed., The Condensed Chemical Dictionary, 9th ed., (New York: Van Nostrand Reinhold Company, 1977), p. 213.
Watanabe et al.--Chem. Abst., vol. 81, (1974), p. 16715v.
Ecanow Bernard
Ecanow Charles S.
Neomed Inc.
Rosen Sam
LandOfFree
Gelatin based synthetic blood and a method of making the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gelatin based synthetic blood and a method of making the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gelatin based synthetic blood and a method of making the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-613141